A048410 Stock Overview
Operates as a biotechnology company. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Hyundai Bioscience Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩14,260.00 |
| 52 Week High | ₩29,100.00 |
| 52 Week Low | ₩12,650.00 |
| Beta | 1.07 |
| 11 Month Change | -17.90% |
| 3 Month Change | -27.91% |
| 1 Year Change | -49.70% |
| 33 Year Change | -47.38% |
| 5 Year Change | -0.28% |
| Change since IPO | 22.93% |
Recent News & Updates
Hyundai Bioscience Co., Ltd.'s (KOSDAQ:048410) Stock Retreats 26% But Revenues Haven't Escaped The Attention Of Investors
Dec 05
Is Hyundai Bioscience (KOSDAQ:048410) A Risky Investment?
Nov 12Recent updates
Hyundai Bioscience Co., Ltd.'s (KOSDAQ:048410) Stock Retreats 26% But Revenues Haven't Escaped The Attention Of Investors
Dec 05Is Hyundai Bioscience (KOSDAQ:048410) A Risky Investment?
Nov 12The Trends At Hyundai Bioscience (KOSDAQ:048410) That You Should Know About
Mar 14Is Hyundai Bioscience (KOSDAQ:048410) Using Too Much Debt?
Feb 07
Imagine Holding Hyundai Bioscience (KOSDAQ:048410) Shares While The Price Zoomed 439% Higher
Jan 03The Trends At Hyundai Bioscience (KOSDAQ:048410) That You Should Know About
Nov 29Shareholder Returns
| A048410 | KR Personal Products | KR Market | |
|---|---|---|---|
| 7D | 0.3% | 1.5% | -1.4% |
| 1Y | -49.7% | -9.6% | -6.6% |
Return vs Industry: A048410 underperformed the KR Personal Products industry which returned -8.2% over the past year.
Return vs Market: A048410 underperformed the KR Market which returned -4.9% over the past year.
Price Volatility
| A048410 volatility | |
|---|---|
| A048410 Average Weekly Movement | 6.5% |
| Personal Products Industry Average Movement | 6.8% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in KR Market | 11.7% |
| 10% least volatile stocks in KR Market | 2.8% |
Stable Share Price: A048410 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A048410's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 54 | Jong-Won Choi | www.hyundaibioscience.com |
Hyundai Bioscience Co., Ltd. operates as a biotechnology company. The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19.
Hyundai Bioscience Co., Ltd. Fundamentals Summary
| A048410 fundamental statistics | |
|---|---|
| Market cap | ₩567.82b |
| Earnings (TTM) | -₩10.44b |
| Revenue (TTM) | ₩15.82b |
35.9x
P/S Ratio-54.4x
P/E RatioIs A048410 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A048410 income statement (TTM) | |
|---|---|
| Revenue | ₩15.82b |
| Cost of Revenue | ₩3.81b |
| Gross Profit | ₩12.01b |
| Other Expenses | ₩22.45b |
| Earnings | -₩10.44b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -262.18 |
| Gross Margin | 75.90% |
| Net Profit Margin | -66.00% |
| Debt/Equity Ratio | 57.6% |
How did A048410 perform over the long term?
See historical performance and comparison